Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

COVID-19 vaccines and multiple sclerosis disease-modifying therapies.

Multiple sclerosis and related disorders·2021

Same author

Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2021

Same author

Evaluation of remote assessments for multiple sclerosis in an in-home setting.

Multiple sclerosis and related disorders·2021

Same author

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement.

Journal of neuroimmunology·2021

Same author

Probing the association between Multiple Sclerosis and Epstein Barr Virus from a therapeutic perspective.

Multiple sclerosis and related disorders·2021

Same author

Can rheumatologists stop causing demyelinating disease?

Multiple sclerosis and related disorders·2021

Search research articles

Related Experiment Video

Updated: May 10, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Targeting Epstein-Barr virus in multiple sclerosis: when and how?

Gavin Giovannoni¹

¹Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.

Current Opinion in Neurology

|March 21, 2024

Summary

Epstein-Barr virus (EBV) is strongly linked to multiple sclerosis (MS). Targeting EBV offers a promising new treatment strategy for MS patients, potentially halting disease progression.

More Related Videos

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

Related Experiment Videos

Last Updated: May 10, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

Area of Science:

Neuroimmunology
Virology
Epidemiology

Background:

Epidemiological studies suggest Epstein-Barr virus (EBV) is a significant factor in multiple sclerosis (MS) etiology.
The precise biological mechanisms linking EBV to MS pathogenesis remain under investigation.

Purpose of the Study:

To review the role of EBV in MS pathogenesis.
To present a rationale for developing EBV-targeted therapies for MS.

Main Methods:

Review of epidemiological, immunological, and virological data.
Analysis of existing and potential therapeutic strategies targeting EBV.

Main Results:

EBV may trigger MS through molecular mimicry or immune dysregulation.
Active EBV infection, cycling between latent and lytic states, is hypothesized to drive MS activity.
Current MS therapies may indirectly target EBV, suggesting broader anti-EBV approaches are warranted.

Conclusions:

EBV is a probable cause of MS and drives disease activity via latent-lytic cycling.
Testing anti-EBV agents, B-cell therapies, and immunotherapies (e.g., T-cells, vaccines) is crucial for MS treatment development.